Antidepressants only benefit severely depressed patients

Antidepressant medications appear to help only severely depressed people, a new analysis has found. – Who benefits from antidepressant drugs? A new study from from the University of Hull published today in PLoS Medicine suggests that antidepressant medicines only benefit some, very severely depressed patients.

Emerging infectious diseases are on the rise

Emerging infectious diseases such as HIV, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Ebola are indeed on the rise. – A team of scientists has shown that emerging infectious diseases such as HIV, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Ebola are indeed on the rise. The team ? including University of Georgia professor John Gittleman and scientists from the Consortium for Conservation Medicine, the Institute of Zoology (London) and Columbia University ? recently published their findings in leading scientific journal Nature.

Vytorin does not appear to be unsafe – American Heart Association

Schering-Plough Corp and Merck & Co are defending their shared cholesterol treatments, Vytorin and Zetia, in advertisements in The New York Times after a failed study generated negative publicity. – Merck/Schering-Plough Pharmaceuticals released results from the ENHANCE trial, which found that the ezetimibe/simvastatin (Zetia/Zocor) combination drug known as Vytorin was no more effective in reducing artery plaque build-up than simvastatin (Zocor) alone. There were no statistically significant differences in the safety of the drugs, which are used to lower cholesterol.

Restless legs syndrome doubles risk of stroke and heart disease

Restless legs syndrome doubles risk of stroke and heart disease

Restless legs syndrome increases risk of stroke and heart diseases in patients because of increased blood pressure and heart rate due to periodic legs movements. – People with restless legs syndrome (RLS) are twice as likely to have a stroke or heart disease compared to people without RLS, and the risk is greatest in those with the most frequent and severe symptoms.